CERT logo

Certara, Inc. Common Stock


CERT: Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The group has a business presence in the United States, EMEA, and other regions, of which a majority of revenue is derived from the United States.


Show CERT Financials

Consumer Interest
SEC Filings

Recent trades of CERT by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quiver Logo

No Whale Activity for this ticker

Institutional Holdings Dashboard

Quarterly net insider trading by CERT's directors and management

Government lobbying spending instances

  • $10,000 Jan 18, 2018 Issue: Health Issues
  • $10,000 Oct 20, 2017 Issue: Health Issues
U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases


Number of mentions of CERT in WallStreetBets Daily Discussion


Recent insights relating to CERT

CNBC Recommendations

Recent picks made for CERT stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in CERT

Corporate Flights

Flights by private jets registered to CERT